TACSTD2 and renal cell carcinoma: In liver cholangiocarcinoma and renal cell carcinoma, TACSTD2 silencing by promoter hypermethylation was associated with enhanced aggressiveness properties such as proliferation, migration, metastasis or advanced tumor stage20,21.